Summary.-The relation between terminal deoxynucleotidyl transferase (TdT) activity, glucocorticoid (GC) receptors and the effect of vincristine-prednisolone (VP) therapy on fresh leukaemia cases was examined. Five of 6 TdT+ leukaemias showed high levels of GC receptors and a favourable response to VP therapy, whereas 1 acute lymphoblastic leukaemia (ALL) and 3 of chronic myelogenous leukaemia (CML) cases in blast crisis with no TdT activity showed low level of GC receptors and poor response to VP therapy.
showed high levels of GC receptors and a favourable response to VP therapy, whereas 1 acute lymphoblastic leukaemia (ALL) and 3 of chronic myelogenous leukaemia (CML) cases in blast crisis with no TdT activity showed low level of GC receptors and poor response to VP therapy.
Significant correlation (r = 0-821, P <0-01) was observed between TdT activity and the number of GC receptor sites in these cases. x2 test showed significant difference (P<0-01) between TdT+ and TdT-leukaemias in the effect of VP. A significant difference (P < 0-01) was also observed between VP-effective and ineffective leukaemias in the number of GC-receptor sites by unpaired t test. Therefore GC receptors may be responsible for the effect of VP on TdT+ leukaemias.
TERMINAL deoxynucleotidyl transferase (TdT) is a DNA polymerase with a unique distribution (Bollum, 1979) . Since the discovery of high TdT activity in blasts of an ALL case (McCaffrey et al., 1973) there have been many studies on this enzyme in leukaemia. Thus far, in most cases of ALL (Coleman et al., 1976; Greenwood et al., 1977) , in about one third of cases with CML in blast crisis (Sarin et al., 1976; Sasaki & Sakamoto, 1977) and in a few cases with acute myelogenous leukaemia (AML) (Stass et al., 1979) , high enzyme activities were reported. Recently, there are some reports suggesting that vincristine-prednisolone (VP) therapy is effective for the treatment of TdT+ leukaemia cases (Marks et al., 1978; Sasaki et al., 1979; Pangalis & Beutler, 1979) .
However, we know of no report on the relation between TdT activity, the level of glucocorticoid (GC) receptors of blasts and the effect of VP therapy on leukaemia. This study aimed to investigate the mechanism of the effect of VP therapy on TdT+ leukaemias.
MATERIALS AND METHODS
Chemicals. Patients whose percentage of blasts in the marrow was reduced to less than one third of the level on admission were defined as "effective cases". Other patients were "'ineffective cases".
Assay for specific glucocorticoid-binding sites. Viable cells from the peripheral blood of patients with leukaemia were used at concentrations between 4 and 6 x 106 cells/ml for the receptor assay. The receptor assay was carried out by slightly modifying the procedure reported by Lippman et al. (1977) .
Dexamethasone dissolved in ethanol was
further diluted in RPMI-1640 medium (10% foetal calf serum). The final concentration of ethanol to dissolve dexamethasone (<040%) did not affect cell viability. Each cell suspension (0-8 ml) in RPMI-1640 medium (10% foetal calf serum) was distributed into small glass tubes. To half of these tubes, 0 2 ml of a 5-fold concentration of 3H-dexamethasone was added. To the other half, 0-2 ml of a 5-fold concentration of 3H-dexamethasone plus a 100-fold excess of unlabelled dexamethasone wa,s added. The binding curves were made by using varying concentrations of 3H-dexamethasone with or without unlabelled dexamethasone. Incubations wAere performed for 2 h at 2100. Every 15 min, the cells were gently mixed. After incubation, the cell suspensions were washed x 3 with cold PBS, and the cells were solubilized in 0 5 ml of Soluene 350 (Packard). Each solubilized sample was transferred to liquid-scintillation vials, and counted in 10 ml of Dimnilume-30 (Packard). The viability of the incubated cells was >96%, as examined by using trypan-blue dye exclusion. Binding sites per cell and equilibriutn dissociation constants were calculated from Scatchard analysis (Scatchard, 1949) assuming that each receptor has only one steroid-binding site. Maximum specific binding at infinite steroid concentrations was obtained from the "x" intercept of the Scatchard plot. The amount of binding, when converted to the number of molecules bound, divided by the cell number used for the assay, yields the number of specific glucocorticoid binding sites/cell.
Preparation of cell extract and enzyme assay.-This was done as described previously (Sasaki et al., 1979) . Leukaemic cells separated from the marrowi-aspirates of fresh leukaemia cases A-ere suspended at 108 cells/ ml in extraction buffer (50mM Tris-HCl, pH 7.6), disrupted by freezing and thawTing with the addition of 0 250/ Triton X-100, and centrifuged at 100,000 g for 1 h. The reaction mixture contained 50mM Tris-HCl at pH 7.5, 30mM KCI, 0 5mM MnCk2, 2mMi dithiothreitol, 10 pg of bovine serum albumin, 0 5 u of poly-dA, 0-25mM [3H]-dGTP and the cell extract. Incubations were for 20 min at 37°C. Aliquots wNere placed on Whatman GF/C filters, and processed according to the method of Chang & Bollum (1971) . The samples were counted in a toluene scintillator using a liquid-scintillation spectrometer. Endogenous radioactivity (no primer) w-as subtracted from the activity of the poly-dA-primed reaction. The enzyme activity was expressed as U/108 nucleated cells. One unit represents 1 nmol of [3H]-dGMP polymerized on to poly-dA for 20 min at 37°C.
Immn nofiuorescence.-The percentage of TdT+ cells was surveyed by using the indirect immunofluorescence method. as reported previously (Sasaki et al., 1980) . Slides were fixed with methanol at 4°C, incubated with rabbit antisera against calf-thymus TdT, and stained with fluoresceinated goat anti-rabbit IgG (Fah')2 fiagments. Cells with fluorescent nuclei wN-ere scored as positive. This antibody shows good reaction with human terminal transferase (Bollum, 1975 (Bollum, , 1979 (Snedecor & Cochran, 1967 kaemia showed a poor response to this therapy ("ineffective" cases). However, only 1 (8.33%) of 12 patients with TdTleukaemia entered into complete remission, and 4 more (33.30o) showed a favourable response ("effective" cases).
In Table I , the x2 test showed a significant difference (P < 0.01) between
TdT+ and TdT-leukaemias in the effect of VP therapy. (CML in myeloblastic crisis) and 4 contained low levels of GC receptor and no TdT activity. These cases showed poor (r = 0 821, P < 0X01) was observed between the enzyme activity and the receptor level. Also, in Table II (Bollum, 1979) . At the infantile stage of rats and mice, another TdT+ cell population appears in peripheral blood, liver, spleen and lung (Bollum, 1979; Sasaki et al., 1980) . Treatment of rats with dexamethasone rapidly induces complete elimination of TdT+ cells from all these tissues (Gregoire et al., 1979; Sasaki et al., 1980) . Therefore, TdT+ cells in normal tissues are markedly sensitive to glucocorticoid hormone. The unique tissue distribution (Bollum, 1979) , glucocorticoid sensitivity and cytochemical characteristics of TdT+ cells (Sasaki & Bollum, in preparation) (Gordon et al., 1978; Marks et al., 1978; Pangalis & Beutler, 1979; Sasaki et al., 1979) .
The finding shown in Table I However, there are also some TdT+ leukaemias which fail to respond to VP. TdT+ ALL (Case 5) was markedly resistant to VP, and blasts in this case contained a low level of GC receptors. In this case, the heterogeneity of blasts might be responsible for the low level of GC receptors and poor response to VP. Alternatively, the level of (C receptor sites in blasts might be more important than the level of TdT activity in predicting the response of leukaemic cases to VP therapy. Further analysis of more leukaemias into the relation between TdT activity, GC receptors and the effect of VP therapy is now in progress.
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